Skip to content
Screener

Health Catalyst HCAT Q4 2025 Annual earnings

Reported March 12, 2026 · After market close

Revenue$74.7MBeat by $711.5K
EPS$0.08Miss by $0.01
Revenue estimate$74.0M
EPS estimate$0.09

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$55.4M
EPS estimate-$0.02

Financials

Q4 2025

Income statement

See full
Revenue$74.7M-6.2%
Gross profit$39.4M+13.5%
Operating income-$86.1M-392%
Net income-$91.0M-340%
EPS (diluted)-$1.30-294%

Balance sheet

See full
Cash & equivalents$50.8M-79.6%
Total debt$171.2M-57.4%
Total equity$245.8M-32.7%
Total assets$502.6M-41.5%

Cash flow

See full
Operating cash flow$9.9M—
CapEx$273.0K-33.9%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$169.05M-60.7%
Enterprise value$289.47M-50.3%
P/S0.5×-0.9×

Profitability

See full
Gross margin48.7%+2.8pp
Operating margin-51.7%-243pp
Net margin-57.2%-167pp

Returns & leverage

See full
Return on equity-58.3%-113pp
Debt / equity0.7×-0.4×
Current ratio1.9×+0.5×

Segments

By segment

See full
Technology$51.9M+0.5%
Accumulated Impairment Losses$22.8M-18.6%

By product

See full
Recurring technology$51.9M+0.5%
Accumulated Impairment Losses$22.8M-18.6%

FAQ

When did Health Catalyst report Q4 2025 earnings?
Health Catalyst (HCAT) reported Q4 2025 earnings on March 12, 2026 after market close.
What were Health Catalyst's Q4 2025 revenue and EPS?
Health Catalyst reported revenue of $74.7M and eps of $0.08 for Q4 2025.
Did Health Catalyst beat estimates in Q4 2025?
Revenue beat the consensus estimate of $74.0M by $711.5K. EPS missed the consensus estimate of $0.09 by $0.01.
How did Health Catalyst's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 6.2% from $79.6M a year earlier and eps grew 100.0% from $0.04.
Where can I find Health Catalyst's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001636422-26-000031) and the 10-K periodic report (0001636422-26-000035) directly on SEC EDGAR. The filing index links above go to sec.gov.